Vincerx Pharma Inc (VINC) - News Archive

In a significant announcement for the biotechnology sector, Vincerx Pharma, Inc. (NASDAQ: VINC) has declared its entry into a non-binding letter of intent (LOI) for a business combination with Global Digital Holdings In...

Vincerx Pharma and Oqory, Inc. Forge Strategic Merger to Enhance Oncology PipelineOn December 27, 2024, Vincerx Pharma, Inc. announced that it has entered into a binding term sheet for a strategic merger with Oqory, Inc...

Vincerx Pharma, Inc. a biopharmaceutical company committed to innovation in the treatment of hematologic and solid tumor cancers, is poised for a significant strategic transformation. On January 28, 2025, Vincerx announ...

Amidst a challenging landscape for biotechnology companies, Vincerx Pharma, Inc. (NASDAQ: VINC) is reportedly in discussions for a significant strategic merger with Oqory, Inc. a move that could reshape its product pipe...

Vincerx Pharma s Promising Advances: VIP943 Shows Initial Clinical Success and Future Potential in Cancer TreatmentIn a landscape where innovative therapies remain crucial to improving patient outcomes, Vincerx Pharma h...

Vincerx Pharma s Proposed Offering and its Impact on Company SharesIn a recent press release, Vincerx Pharma, Inc. (Nasdaq: VINC), a pharmaceutical company based in Palo Alto, California, announced a proposed underwritt...

presents exciting developments in the field of cancer therapeutics with Vincerx Pharma s groundbreaking research. The company s presentations at the American Association for Cancer Research (AACR) Annual Meeting 2024 an...

The American Association for Cancer Research (AACR) Annual Meeting in 2024 hosted a significant event for Vincerx Pharma Inc, as the company presented preliminary Phase 1 data for their promising drug candidate, VIP236....

Vincerx Pharma s Enitociclib Shows Promise in Combating Lymphoma, According to National Institutes of Health (NIH) ReportVincerx Pharma, a leading biopharmaceutical company, recently announced the remarkable clinical ef...

IntroductionIn an exciting development for the field of oncology, Vincerx Pharma Inc. presented its latest preclinical findings at the prestigious ASH 2023 conference. The company s VersAptx platform, known for its cutt...